By Dan Darrow
October 20, 2022
Intraday Update: GSK
GSK is having a strong start this morning, and the early rally is sending the stock up near the key 50day sma. Since the trade was initiated, that moving average has walked lower, and while the initial target for the Nov18 $30 call was 32+, we are going to roll up sooner seeing as though the 50day sma (31.59) is now underneath that level. The plan will be to close the current call and roll up to a lower debit Nov18 $32 - $35 call spread. The next target is 32.75+.
Trader Author Portfolio Holdings
**As of the date and time of publication